EMQN Integrates Trinean’s DropSense™ Into Its Standards Qc Procedures and Quality Assessment Schemes
News Feb 17, 2016
EMQN and Trinean have announced that the DropSense™96 has been integrated by EMQN as the standard QC tool for DNA samples used in its External Quality Assessment (EQA) schemes.
EMQN’s EQA schemes are designed to test the whole analytical process of a clinical laboratory; the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
The EQA process, which allows diagnostic labs to benchmark and improve their laboratory performance, requires high quality materials and EMQN has adopted the Trinean DropSense™96 reader with its innovative purity analysis cDrop™ software for the QC of all DNA material used.
Dr. Simon Patton, Director of EMQN, said: “The integration of the DropSense™96 reader has significantly improved our QC processes enabling us to rapidly assess the quality of our EQA materials. We look forward to working with Trinean as we further integrate its technology in to our activities.”
“Trinean is delighted to partner with EMQN and contribute to the continuous improvement in the standard to diagnostic clinical genetic testing. Our DropSense™96 technology matches the expectations of EMQN in terms of robustness, throughput need and sample QC info,” adds Yvan Sergeant, VP Commercial Operations at Trinean.
“Our simple drop-insert-quantify approach allows quick DNA quantification on the DropSense™96 beyond the capabilities of other quantification methods. Both the DropSense™96 and the smaller Xpose™ reader, fit for manual sample processing, are able to provide DNA specific quantification as well as impurity levels ensuring the best read-out quality of a genetic sample.”
y conjuring the spell “Lumos!” wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program that “lights up” cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their patients.READ MORE
It is well known that psychiatric stress is associated with accelerated aging. Now, a new study shows that a gene mutation interacts with multiple types of psychiatric stress including post-traumatic stress disorder (PTSD), pain and sleep disturbances in association with cellular aging.READ MORE